Vanguard Group Inc Innoviva, Inc. Transaction History

Vanguard Group Inc

$6.44 Trillion
Q3 2025

A detailed history of Vanguard Group Inc transactions in Innoviva, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 7,097,346 shares of INVA stock, worth $158 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,097,346

Previous 7,179,262 1.14%

Holding current value

$158 Million

Previous $144 Million 10.2%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	SELL	$18.17 - $20.92 $1.49 Million - $1.71 Million	-81,916 Reduced 1.14%	7,097,346 $130 Million
Q2 2025 Aug 11, 2025	BUY	$17.1 - $21.8 $15.1 Million - $19.2 Million	880,649 Added 13.98%	7,179,262 $144 Million
Q1 2025 May 09, 2025	SELL	$17.21 - $18.98 $241,249 - $266,061	-14,018 Reduced 0.22%	6,298,613 $114 Million
Q4 2024 Feb 11, 2025	BUY	$17.35 - $20.32 $1.47 Million - $1.73 Million	84,934 Added 1.36%	6,312,631 $110 Million
Q3 2024 Nov 13, 2024	BUY	$16.33 - $20.04 $771,543 - $946,829	47,247 Added 0.76%	6,227,697 $120 Million

Q2 2024 Aug 13, 2024	SELL	$14.4 - $16.4 $1.52 Million - $1.73 Million	-105,563 Reduced 1.68%	6,180,450 $101 Million
Q1 2024 May 10, 2024	SELL	$14.56 - $16.78 $6.21 Million - $7.16 Million	-426,430 Reduced 6.35%	6,286,013 $95.8 Million
Q4 2023 Feb 14, 2024	SELL	$12.32 - $16.27 $61,526 - $81,252	-4,994 Reduced 0.07%	6,712,443 $108 Million
Q3 2023 Nov 14, 2023	SELL	$12.37 - $13.89 $882,191 - $990,593	-71,317 Reduced 1.05%	6,717,437 $87.3 Million
Q2 2023 Aug 14, 2023	SELL	$11.39 - $13.72 $4.66 Million - $5.61 Million	-408,817 Reduced 5.68%	6,788,754 $86.4 Million
Q1 2023 May 15, 2023	BUY	$10.73 - $13.6 $1.35 Million - $1.7 Million	125,359 Added 1.77%	7,197,571 $81 Million
Q4 2022 Feb 10, 2023	BUY	$11.8 - $13.78 $876,256 - $1.02 Million	74,259 Added 1.06%	7,072,212 $93.7 Million
Q3 2022 Nov 14, 2022	BUY	$11.61 - $15.22 $313,504 - $410,985	27,003 Added 0.39%	6,997,953 $81.2 Million
Q2 2022 Aug 12, 2022	BUY	$14.32 - $19.88 $2.11 Million - $2.93 Million	147,560 Added 2.16%	6,970,950 $103 Million
Q1 2022 May 13, 2022	BUY	$15.39 - $20.25 $356,971 - $469,698	23,195 Added 0.34%	6,823,390 $132 Million
Q4 2021 Feb 14, 2022	BUY	$15.91 - $18.72 $1.6 Million - $1.88 Million	100,475 Added 1.5%	6,800,195 $117 Million
Q3 2021 Nov 12, 2021	SELL	$13.06 - $17.24 $1.28 Million - $1.69 Million	-98,297 Reduced 1.45%	6,699,720 $112 Million
Q2 2021 Aug 13, 2021	BUY	$11.45 - $13.96 $77.8 Million - $94.9 Million	6,798,017 New	6,798,017 $91.2 Million

Others Institutions Holding INVA

# of Institutions

281

Shares Held

82.7M

Call Options Held

13.2K

Put Options Held

156K

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.55B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Innoviva, Inc. Transaction History